154 related articles for article (PubMed ID: 1980321)
1. A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and alpha-methyl-p-tyrosine.
Nakagami Y; Nomura K; Kusakabe K; Miko N; Tsushima T; Demura H
Jpn J Med; 1990; 29(3):329-33. PubMed ID: 1980321
[TBL] [Abstract][Full Text] [Related]
2. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
[TBL] [Abstract][Full Text] [Related]
3. Results of [131I]metaiodobenzylguanidine therapy administered to three patients with malignant pheochromocytoma.
Schvartz C; Gibold C; Vuillemin B; Delisle MJ
J Nucl Biol Med (1991); 1991; 35(4):305-7. PubMed ID: 1823842
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of iodine-131 metaiodobenzylguanidine in patients with metastatic pheochromocytoma.
Mangner TJ; Tobes MC; Wieland DW; Sisson JC; Shapiro B
J Nucl Med; 1986 Jan; 27(1):37-44. PubMed ID: 3941363
[TBL] [Abstract][Full Text] [Related]
5. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy.
Pujol P; Bringer J; Faurous P; Jaffiol C
Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270
[TBL] [Abstract][Full Text] [Related]
6. 131I-metaiodobenzylguanidine therapy for malignant pheochromocytoma.
Sakahara H; Endo K; Saga T; Hosono M; Kobayashi H; Konishi J
Ann Nucl Med; 1994 May; 8(2):133-7. PubMed ID: 7521194
[TBL] [Abstract][Full Text] [Related]
7. [131I]metaiodobenzylguanidine treatment of a malignant paraganglioma.
Baulieu JL; Guilloteau D; Calais G; Lefloch O; Besnard JC
J Nucl Biol Med (1991); 1991; 35(4):313-4. PubMed ID: 1823844
[TBL] [Abstract][Full Text] [Related]
8. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine.
Campeau RJ; Garcia OM; Correa OA; Rege AB
South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724
[TBL] [Abstract][Full Text] [Related]
9. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
[TBL] [Abstract][Full Text] [Related]
10. Treatment of malignant phaeochromocytoma, paraganglioma and carcinoid tumours with 131I-metaiodobenzylguanidine.
Bomanji J; Britton KE; Ur E; Hawkins L; Grossman AB; Besser GM
Nucl Med Commun; 1993 Oct; 14(10):856-61. PubMed ID: 8233228
[TBL] [Abstract][Full Text] [Related]
11. [131I]metaiodobenzylguanidine therapy of malignant pheochromocytoma: interference of medication.
Hoefnagel CA; Schornagel J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):308-12. PubMed ID: 1823843
[TBL] [Abstract][Full Text] [Related]
12. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
Shapiro B
Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
[TBL] [Abstract][Full Text] [Related]
13. [Radionuclide therapy of Sipple syndrome using iodine-131 metaiodobenzylguanidine].
Furusawa M; Shimomura O; Tomiguchi S; Hirota Y; Takahashi M; Yamauchi J; Iwaoka D; Satoh T
Kaku Igaku; 1992 Sep; 29(9):1133-8. PubMed ID: 1360550
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case].
Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700
[TBL] [Abstract][Full Text] [Related]
15. [A new medico-nuclear outlook for the diagnosis and treatment of pheochromocytomas: 131I-meta-iodobenzylguanidine (131I-MIBG). Comments on results obtained].
Troncone L; Rufini V; Danza FM; Valenza V; Montemaggi P; Bonifazi N
Radiol Med; 1986 Jun; 72(6):485-94. PubMed ID: 3715090
[TBL] [Abstract][Full Text] [Related]
16. A case of Sipple's syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine.
Sasaki M; Iwaoka T; Yamauchi J; Tokunaga H; Naomi S; Inoue J; Oishi S; Umeda T; Sato T
Endocr J; 1994 Apr; 41(2):155-60. PubMed ID: 7951563
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up].
Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T
Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
Porzig A; Matthay KK; Dubois S; Pampaloni M; Damon L; Hawkins R; Goldsby R; Hollinger F; Fitzgerald P
Horm Metab Res; 2012 Jun; 44(7):539-42. PubMed ID: 22588707
[TBL] [Abstract][Full Text] [Related]
19. Preliminary results of [131]metaiodobenzylguanidine treatment in metastatic malignant pheochromocytoma.
Colombo L; Lomuscio G; Vignati A; Dottorini ME
J Nucl Biol Med (1991); 1991; 35(4):300-4. PubMed ID: 1823841
[TBL] [Abstract][Full Text] [Related]
20. Therapy of pheochromocytoma with [131I]metaiodobenzylguanidine.
Fischer M
J Nucl Biol Med (1991); 1991; 35(4):292-4. PubMed ID: 1823839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
